Vascular dementia: Clinical, neuroradiologic and neuropathologic aspects

Panminerva Medica

Volumn 49, Issue 4, 2007, Pages 197-207

  Murray, M E ^a   Knopman, D S ^b   Dickson, D W ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cerebrovascular disorders; Dementia, vascular, diagnosis; Neuroradiography; Risk factors

Indexed keywords

AGED; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; REVIEW; RISK FACTOR;

AGED; DEMENTIA, VASCULAR; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38849095847     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7.
2. Irizarry M, Hyman B. Alzheimer's Disease. In: Batchelor T, Cudkowicz ME, editors. Principles of Neuroepidemiology. Boston: Butterworth-Heinemann, 2001. p.
3. nd edition London: Martin Dunitz; 2004.
4. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology 1998;51:728-33.
5. th edition. Washington, DC: American Psychiatric Association; 1994.
6. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-707.
7. Román GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, López-Pousa S et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004;226:81-7.
8. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994;5:130-2.
9. Sachdev P. Vascular cognitive disorder. Int J Geriatr Psychiatry 1999;14:402-3.
10. Santamaria Ortiz J, Knight PV. Binswanger's disease, leukoaraiosis and dementia. Age Ageing 1994;23:75-81.
11. Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet 1992;340:645-8.
12. Knopman DS. Dementia and cerebrovascular disease. Mayo Clin Proc 2006;81:223-30.
13. th edition. Washington, DC: American Psychiatric Association; 1994
14. Cosentino SA, Jefferson AL, Carey M, Price CC, Davis-Garrett K, Swenson R et al. The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm. Clin Neuropsychol 2004;18:6-21.
15. Pohjasvaara T, Mäntylä R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke 2000;31:2952-7.
16. Pohjasvaara T, Mäntylä R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10 NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke 2000:2952-7.
17. Desmond DW. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci 2004;226:3-7.
18. Grossman H, Bergmann C, Parker S. Dementia: a brief review. Mt Sinai J Med 2006;73:985-92.
19. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-82.
20. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 2004;35:2620-2.
21. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke 1997;28:459-63.
22. Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005;64:1548-52.
23. Liu HC, Fuh JL, Wang SJ, Liu CY, Larson EB, Lin KN et al. Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord 1998;12:127-34.
24. Azad NA, Al Bugami M, Loy-English I. Gender differences in dementia risk factors. Gend Med 2007;4:120-9.
25. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002;58:1175-81.
26. Roman GC. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis 2005;20(Suppl 2):91-100.
27. Kalaria RN. Advances in molecular genetics and pathology of cerebrovascular disorders. Trends Neurosci 2001;24:392-400.
28. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10.
29. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993;3:256-9.
30. Joutel A, Dodick DD, Parisi JE, Cecillon M, Tournier-Lasserve E, Bousser MG et al. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol 2000;47:388-91.
31. Mazzei R, Guidetti D, Ungaro C, Conforti FL, Muglia M, Cenacchi G et al. First Evidence of a Pathogenic Insertion in the NOTCH3 Gene Causing CADASIL. J Neurol Neurosurg Psychiatry 2007 Sep 14; [Epub ahead of print].
32. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill-Gutierrez E, Goldberg MA et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol 1992;49:549-54.
33. McMurtray AM, Liao A, Haider J, Licht E, Mendez MF. Cognitive performance after lacunar stroke correlates with leukoaraiosis severity. Cerebrovasc Dis 2007;24:271-6.
34. Roman GC. Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 1987;258:1782-8.
35. Gouw AA, Van der Flier WM, van Straaten EC, Barkhof F, Ferro JM, Baezner H et al. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol 2006;253:1189-96.
36. Tatemichi TK, Desmond DW, Prohovnik I, Cross DT, Gropen TI, Mohr JP et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992;42:1966-79.
37. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 2006;60:677-87.
38. Crystal HA, Dickson DW, Sliwinski MJ, Lipton RB, Grober E, Marks-Nelson H et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 1993;34:566-73.
39. Jack CR Jr, Dickson DW, Parisi JE, Xu YC, Cha RH, O' Brien PC et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-7.
40. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007;61:435-45.
41. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
42. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991:239-59.
43. Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C. Absence of cholinergic deficits in "pure" vascular dementia. Neurology 2005;64:132-3.
44. Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev 2004:CD004395.
45. Erkinjuntti T, Roman G, Gauthier S. Treatment of vascular dementia - evidence from clinical trials with cholinesterase inhibitors. J Neurol Sci 2004;226:63-66.
46. Firdaus M, Mathew MK, Wright J. Health promotion in older adults: the role of lifestyle in the metabolic syndrome. Geriatrics 2006;61:18-22, 24-15.
47. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001;22:407-12.
48. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004;226:75-80.
49. Pantoni L, Sarti C, Alafuzoff I, Jellinger K, Munoz DG, Ogata J et al. Postmortem examination of vascular lesions in cognitive impairment: a survey among neuropathological services. Stroke 2006;37:1005-9.
50. Englund E, Brun A, Persson B. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1987;1:156-70.
51. Dickson DW. Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol 2005;109:14-24.
52. Amador-Ortiz C, Ahmed Z, Zehr C, Dickson DW. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol 2007;113:245-52.
53. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD et al. Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vase Biol 2003;23:2055-62.
54. Love S. Neuropathological investigation of dementia: a guide for neurologists. J Neurol Neurosurg Psychiatry 2005;76(Suppl 5):8-14.
55. Takao M, Koto A, Tanahashi N, Fukuuchi Y, Takagi M et al. Pathologic findings of silent, small hyperintense foci in the basal ganglia and thalamus on MRI. Neurology 1999;52:666-8.
56. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982;32:871-6.
57. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol 1968;12:1-15.
58. DeReuck J, Schaumburg HH. Periventricular atherosclerotic leukoencephalopathy. Neurology 1972;22:1094-7.
59. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749-3.
60. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 2002;977:9-23.
61. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006;37:1391-8.
62. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 2001;14:668-76.
63. Challa VR, Thore CR, Moody DM, Anstrom JA, Brown WR. Increase of white matter string vessels in Alzheimer's disease. J Alzheimers Dis 2004;6:379-83.
64. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
65. Fisher CM. Binswanger's encephalopathy: a review. J Neurol 1989:65-79.
66. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S115-123.
67. Rosenberg GA, Sullivan N, Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 2001;32:1162-8.
68. Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann NY Acad Sci 2000:239-43.
69. Jellinger KA. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 2002;203-204:153-7.
70. Dickson DW. Neuropathology of Alzheimer's disease and other dementias. Clin Geriatr Med 2001;17:209-28.
71. Haglund M, Passant U, Sjöbeck M, Ghebremedhin E, Englund E. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 2006;21:681-7.
72. Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998:690-4.
73. Smith EE, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep 2003;5:260-6.
74. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990: 1124-6.
75. Wattendorff AR, Frangione B, Luyendijk W, Bots GT. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J Neurol Neurosurg Psychiatry 1995:699-705.
76. Lammie GA. Pathology of small vessel stroke. Br Med Bull 2000;56:296-306.
77. Beach TG, Sue L, Scott S, Layne K, Newell A, Walker O, et al. Hippocampal sclerosis dementia with tauopathy. Brain Pathol 2003;13:263-78.